Results 11 to 20 of about 15,126 (225)

Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats

open access: yesTranslational Psychiatry, 2023
Alcohol Use Disorder (AUD) adversely affects the lives of millions of people, but still lacks effective treatment options. Recent advancements in psychedelic research suggest psilocybin to be potentially efficacious for AUD. However, major knowledge gaps
Jonathan R. Reinwald   +6 more
doaj   +1 more source

Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder

open access: yesTranslational Psychiatry, 2023
Preliminary clinical findings, supported by preclinical studies employing behavioral paradigms such as marble burying, suggest that psilocybin may be effective in treating obsessive-compulsive disorder.
Sandeep Singh   +9 more
doaj   +1 more source

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial

open access: yesBJPsych Open, 2023
Background Randomised controlled trials (RCTs) of psilocybin have reported large antidepressant effects in adults with major depressive disorder and treatment-resistant depression (TRD).
Muhammad Ishrat Husain   +10 more
doaj   +1 more source

Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice

open access: yesFrontiers in Pharmacology, 2023
The classical psychedelic psilocybin is of interest as a treatment for alcohol use disorder (AUD). This study investigated the effects of psilocybin on voluntary ethanol consumption in adult male and female C57BL/6J mice administered saline or psilocybin
Kenneth Alper   +9 more
doaj   +1 more source

A systematic review to assess the use of psilocybin in the treatment of headaches

open access: yesEuropean Psychiatry, 2023
Introduction Psilocybin is a naturally occurring psychedelic compound whose effects have been seen in studies for treatment of depression, anxiety and pain management.
S. Bhanot   +4 more
doaj   +1 more source

The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action

open access: yesFrontiers in Pharmacology, 2020
Serotonergic agonist psilocybin is a psychedelic with antidepressant potential. Sleep may interact with psilocybin’s antidepressant properties like other antidepressant drugs via induction of neuroplasticity. The main aim of the study was to evaluate the
Daniela Dudysová   +28 more
doaj   +1 more source

Self unbound: ego dissolution in psychedelic experience [PDF]

open access: yes, 2017
Users of psychedelic drugs often report that their sense of being a self or ‘I’ distinct from the rest of the world has diminished or altogether dissolved.
Gerrans, Philip, Letheby, Chris
core   +2 more sources

Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity

open access: yesChinese Medical Journal, 2023
. Background:. Posttraumatic stress disorder (PTSD) and depression are highly comorbid. Psilocybin exerts substantial therapeutic effects on depression by promoting neuroplasticity.
Yingjie Du   +7 more
doaj   +1 more source

The varieties of the psychedelic experience: A preliminary study of the association between the reported subjective effects and the binding affinity profiles of substituted phenethylamines and tryptamines [PDF]

open access: yes, 2018
Classic psychedelics are substances of paramount cultural and neuroscientific importance. A distinctive feature of psychedelic drugs is the wide range of potential subjective effects they can elicit, known to be deeply influenced by the internal state of
Erowid, Earth   +6 more
core   +2 more sources

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans [PDF]

open access: yes, 2016
Ayahuasca is an Amazonian psychotropic plant tea typically obtained from two plants, Banisteriopsis caapi and Psychotria viridis. It contains the psychedelic 5-HT2A and sigma-1 agonist N,N-dimethyltryptamine (DMT) plus ß-carboline alkaloids with ...
Alonso, Joan Francesc   +12 more
core   +3 more sources

Home - About - Disclaimer - Privacy